分子癌症治疗(Molecular Cancer Therapeutics)是一本由American Association for Cancer Research Inc.出版的一本医学-肿瘤学学术刊物,主要报道医学-肿瘤学相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于2001年,出版周期Monthly。2021-2022年最新版WOS分区等级:Q1,2023年发布的影响因子为5.3,CiteScore指数11.2,SJR...
A universal voice for science and scientists, the Journal of Molecular Medicine & Therapeutics fulfills its mission of advancing science and serving the society, by communicating the essential value of science to the general public and promoting the adva
PD-L1P146Ris prognostic and a negative predictor of response to immunotherapy in gastric cancer Qing Li, Zhi-Wei Zhou, Jia Lu, Hao Luo, ... Cheng-Xiong Xu Pages 621-631 View PDF select article Type I IFNs repolarized a CD169+ macrophage population with anti-tumor potentials in hepatocell...
16. This theory was initially applied to infectious diseases but not to anticancer therapy due to insufficient knowledge of the etiology and biology of cancer14,16; however, this concept has
Our retrospective study aimed to compare the efficacy of chemotherapy and crizotinib in the first-line treatment of ROS1-rearranged advanced lung cancer and evaluate various clinical and molecular factors that might impact crizotinib efficacy in real-world practice. Methods Treatment responses, survival ...
REVIEW New approaches to molecular cancer therapeutics Ian Collins & Paul Workman Cancer drug development is leading the way in exploiting molecular biological and genetic information to develop 'personalized' medicine. The new paradigm is to develop agents that target the precise molecular pathology ...
For instance, CAFs can produce TGFβ, fibroblast growth factor 5 (FGF5), and hepatocyte growth factor (HGF) to facilitate the invasion, proliferation, and therapy resistance of cancer cells [19]. On the contrary, CAFs can exert tumour-inhibiting functions by enhancing anticancer immunity, ...
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics Diana Bautista-Sánchez, Cristian Arriaga-Canon, Abraham Pedroza-Torres, Inti Alberto De La Rosa-Velázquez, ... Luis A. Herrera Pages 409-420 ...
have all indicated promising pathways in the realm of cancer therapeutics. Early-stage research and clinical experiments have started to reveal the effectiveness and transformative potential of CRISPR in the context of cancer treatment. These investigations have not only yielded hopeful outcomes but have...
Breast cancer, the most frequent female malignancy, is often curable when detected at an early stage. The treatment of metastatic breast cancer is more challenging and may be unresponsive to conventional therapy. Immunotherapy is crucial for treating met